Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Real-Time Process Adjustments during Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Real-Time Process Adjustments during Manufacturing – V 2.0

Standard Operating Procedure for Real-Time Process Adjustments during Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/139/2025
Supersedes SOP/SIM/139/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This Standard Operating Procedure (SOP) describes the methodology for identifying, executing, documenting, and evaluating real-time process adjustments during sterile injectable manufacturing. The goal is to minimize batch failure risks, maintain consistent quality, and ensure compliance with validated manufacturing

conditions under GMP guidelines.

2. Scope

This SOP applies to all sterile injectable manufacturing processes involving critical process parameters (CPPs) such as temperature, pressure, fill volume, mixing speed, and filter flow rate that may require adjustment based on real-time monitoring and feedback systems.

3. Responsibilities

  • Manufacturing Operators: Monitor critical parameters continuously and report any drift or deviation immediately.
  • Production Supervisor: Assess process trends, authorize and execute minor real-time adjustments as per pre-approved ranges.
  • Quality Assurance (QA): Review and approve any deviation or adjustment outside validated ranges. Ensure proper documentation.
  • Engineering/Maintenance: Investigate equipment-related causes and assist in technical resolution if adjustments are linked to machinery behavior.
See also  Sterile Injectable Manufacturing: SOP for Monitoring Temperature during Sterile Filling - V 2.0

4. Accountability

The Production Head is accountable for ensuring that real-time process adjustments are compliant with the validated ranges and documented per GMP and quality requirements.

5. Procedure

5.1 Definition of Real-Time Adjustment

  1. A real-time process adjustment is a controlled change in process conditions made during batch execution in response to monitored trends or feedback signals to avoid a process deviation or failure.

5.2 Pre-Defined Adjustment Ranges

  1. Each process parameter must have a validated acceptable operating range defined in the Batch Manufacturing Record (BMR) or Master Formula Record (MFR).
  2. Operators shall not exceed the lower or upper bound of validated ranges without QA review and deviation initiation.

5.3 Monitoring Systems

  1. Install sensors and automated systems for real-time tracking of parameters like:
    • Temperature (e.g., during solution preparation or sterilization)
    • Pressure (e.g., in filtration lines)
    • Flow rates (e.g., during filtration or filling)
    • Fill volumes (e.g., vial filling line)
  2. Operators must verify readings at defined intervals and ensure logs are maintained.
See also  Sterile Injectable Manufacturing: SOP for Calibration of Pressure Gauges in Manufacturing Areas - V 2.0

5.4 Execution of Adjustments

  1. Operator identifies trend drift approaching a critical limit and informs the supervisor.
  2. Supervisor verifies the trend and evaluates the need for adjustment within allowed ranges.
  3. Adjustment is made (e.g., reducing stirring speed from 120 RPM to 110 RPM to stabilize temperature).
  4. Adjustment must be documented in the Process Adjustment Log (Annexure-1).
  5. QA must verify the final parameter and counter-sign the adjustment entry.

5.5 Documentation

  1. Details of each adjustment must include:
    • Date and Time
    • Batch Number
    • Parameter Adjusted
    • Before and After Value
    • Reason for Adjustment
    • Approval Signature
  2. Update associated records like BMR, SCADA logs, or PLC trend reports if applicable.

5.6 Evaluation of Impact

  1. QA shall assess the adjustment post-batch completion to determine:
    • If product quality was maintained
    • If similar trends exist in historical batches
    • If CAPA is required to revise process controls or retrain staff

5.7 Non-Compliant Adjustments

  1. If an adjustment is found outside validated ranges, treat it as a deviation and initiate a deviation report immediately.
  2. Product impact assessment must be conducted and decision made regarding reprocessing, hold, or rejection.
See also  Sterile Injectable Manufacturing: SOP for Review of Batch Manufacturing Records - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CPP: Critical Process Parameter
  • QA: Quality Assurance
  • RPM: Revolutions Per Minute
  • BMR: Batch Manufacturing Record
  • SCADA: Supervisory Control and Data Acquisition

7. Documents

  1. Process Adjustment Log – Annexure-1
  2. SCADA or PLC Report Printouts – Annexure-2

8. References

  • ICH Q8 – Pharmaceutical Development
  • ICH Q10 – Pharmaceutical Quality System
  • WHO Technical Report Series on GMP

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Process Adjustment Log

Date Batch No. Parameter Before After Reason Operator QA Verified By
22/06/2025 INJ/167/2025 Mixing Speed 120 RPM 110 RPM Foaming observed Ravi Mehta Sunita Reddy

Annexure-2: SCADA Printout Sample

Timestamp Parameter Value Comment
22/06/2025 10:45 Temperature 25.6°C Stable
22/06/2025 11:00 Mixing Speed 110 RPM Adjusted due to foaming

Revision History

Revision Date Revision No. Details Reason Approved By
01/08/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Integrated real-time SCADA/PLC documentation Process improvement QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Compressed Air System in Mixing Units – V 2.0
Next Post: Biosimilars: SOP for Polishing Step Using Size Exclusion Chromatography – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version